Skip to content
alfuzosin
EntityQ2736873· pop 19· linked from 608 articles

Also known as SL-77499-10, SL-7749910, Uroxatral®, (±)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide, Alfuzosina, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide, Alfuzosine, Alfuzosinum

Alfuzosin, sold under the brand name Uroxatral among others, is a medication of the α1 blocker class. It is used to treat benign prostatic hyperplasia (BPH).

Key facts

Drug.H
27
Drug.N
5
Drug.O
4
Drug.Watchedfields
changed
Drug.class
α1 blocker
Drug.verifiedrevid
477247048
Drug.image
Alfuzosin.svg
Drug.image_class
skin-invert-image
Drug.width
275
Drug.tradename
Uroxatral, others
Drug.MedlinePlus
a64002
Drug.DailyMedID
Alfuzosin
Drug.pregnancy_AU
B2
Drug.routes_of_administration
By mouth
Drug.legal_UK
POM
Drug.legal_US
Rx-only
Drug.bioavailability
49%
Drug.protein_bound
82–90%

via Wikipedia infobox

~4 min read

Encyclopedic overview

11 sections
Contents
  • Clinical information
  • Side effects
  • Indications for use
  • Contraindications
  • Pharmacological properties
  • Chemistry
  • Society and culture
  • History
  • Brand names
  • Synthesis
  • References

Alfuzosin, sold under the brand name Uroxatral among others, is a medication of the α1 blocker class. It is used to treat benign prostatic hyperplasia (BPH).

As an antagonist of the α1-adrenergic receptor, it works by relaxing the muscles in the prostate and bladder neck, making urination easier.

Excerpted from Wikipedia’s “alfuzosin” article, available under the CC BY-SA 4.0 licence.

Gallery (3)